These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27040447)

  • 1. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
    Tsai PC; Kuo HT; Hung CH; Tseng KC; Lai HC; Peng CY; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Tai CM; Lin CW; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Yeh ML; Huang CF; Hsieh MH; Huang JF; Dai CY; Chung WL; Chen CY; Yu ML;
    J Hepatol; 2023 Feb; 78(2):281-292. PubMed ID: 36208843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance.
    Tong MJ; Theodoro CF; Salvo RT
    J Dig Dis; 2018 Jul; 19(7):411-420. PubMed ID: 29889353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
    Kanwal F; Kramer J; Asch SM; Chayanupatkul M; Cao Y; El-Serag HB
    Gastroenterology; 2017 Oct; 153(4):996-1005.e1. PubMed ID: 28642197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
    El-Serag HB; Kanwal F; Richardson P; Kramer J
    Hepatology; 2016 Jul; 64(1):130-7. PubMed ID: 26946190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C.
    Hedenstierna M; Nangarhari A; Weiland O; Aleman S
    Clin Infect Dis; 2016 Sep; 63(6):723-9. PubMed ID: 27282709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.
    Le AK; Zhao C; Hoang JK; Tran SA; Chang CY; Jin M; Nguyen NH; Yasukawa LA; Zhang JQ; Weber SC; Garcia G; Nguyen MH
    Aliment Pharmacol Ther; 2017 Sep; 46(6):605-616. PubMed ID: 28766727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
    Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of chronic hepatitis C patients treated with interferon-alpha: risk of cirrhosis and hepatocellular carcinoma in a single center over 10 years.
    Lee HJ; Yeon JE; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Kim JH; Seo YS; Yim HJ; Byun KS
    Intervirology; 2015; 58(1):14-21. PubMed ID: 25592614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Nahon P; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Roudot-Thoraval F; Audureau E;
    Gastroenterology; 2018 Nov; 155(5):1436-1450.e6. PubMed ID: 30031138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
    Chang CW; Hsu WF; Tseng KC; Chen CY; Cheng PN; Hung CH; Lo CC; Bair MJ; Chen CH; Lee PL; Lin CY; Kuo HT; Chen CT; Yang CC; Huang JF; Tai CM; Hu JT; Lin CL; Su WW; Tsai WL; Huang YH; Cheng CY; Lin CL; Wang CC; Yang SS; Mo LR; Chen GY; Chang CC; Wang SJ; Huang CS; Hsieh TY; Lin CW; Lee TH; Chong LW; Huang CW; Chang SN; Tsai MC; Hsu SJ; Kao JH; Liu CJ; Liu CH; Lin HC; Tsai PC; Yeh ML; Huang CF; Dai CY; Chuang WL; Yu ML; Peng CY
    Dig Dis Sci; 2024 Sep; 69(9):3501-3512. PubMed ID: 38965159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis.
    Mecci AJ; Kemos P; Leen C; Lawson A; Richardson P; Khakoo SI; Agarwal K; Mutimer D; Rosenberg WM; Foster GR; Irving WL;
    Aliment Pharmacol Ther; 2019 Jul; 50(2):204-214. PubMed ID: 31149748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
    van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
    J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
    Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
    Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.
    Aleman S; Rahbin N; Weiland O; Davidsdottir L; Hedenstierna M; Rose N; Verbaan H; Stål P; Carlsson T; Norrgren H; Ekbom A; Granath F; Hultcrantz R
    Clin Infect Dis; 2013 Jul; 57(2):230-6. PubMed ID: 23616492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
    Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
    Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
    McDonald SA; Pollock KG; Barclay ST; Goldberg DJ; Bathgate A; Bramley P; Dillon JF; Fraser A; Innes HA; Kennedy N; Morris J; Went A; Hayes PC; Hutchinson SJ
    J Viral Hepat; 2020 Mar; 27(3):270-280. PubMed ID: 31696575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.